Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,651 | 99 | 58.5% |
| Travel and Lodging | $1,074 | 2 | 38.0% |
| Education | $99.99 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,221 | 11 | $0 (2024) |
| ABBVIE INC. | $626.51 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $260.97 | 10 | $0 (2024) |
| Celgene Corporation | $116.09 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.73 | 5 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $64.78 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.55 | 4 | $0 (2022) |
| PFIZER INC. | $57.83 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $53.91 | 3 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $52.17 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,325 | 27 | Boston Scientific Corporation ($808.49) |
| 2023 | $457.71 | 27 | ABBVIE INC. ($219.21) |
| 2022 | $213.85 | 14 | Janssen Biotech, Inc. ($43.97) |
| 2021 | $692.31 | 26 | BOSTON SCIENTIFIC CORPORATION ($388.57) |
| 2020 | $136.39 | 8 | AbbVie Inc. ($41.08) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology | ||||||
| 11/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: VIROLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Immunology | ||||||
| 06/19/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI, RINVOQ | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Neuroscience | ||||||
| 06/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Neuroscience | ||||||
| 04/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Axios_ENDO | ||||||
| 03/21/2024 | Boston Scientific Corporation | SpyGlass (Device) | Travel and Lodging | In-kind items and services | $778.20 | General |
| Category: SpyGlass_ENDO | ||||||
| 03/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Neuroscience | ||||||
| 03/12/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2024 | Boston Scientific Corporation | Dreamtome RX 49 (Device) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: Dreamtome_ENDO | ||||||
| 02/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 568 | 642 | $494,821 | $75,265 |
| 2022 | 15 | 670 | 742 | $606,751 | $89,642 |
| 2021 | 19 | 740 | 800 | $524,591 | $84,043 |
| 2020 | 14 | 582 | 624 | $291,005 | $67,656 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 165 | 172 | $196,072 | $29,405 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 115 | $23,575 | $10,128 | 43.0% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 31 | 34 | $27,398 | $8,701 | 31.8% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 18 | 24 | $25,768 | $6,867 | 26.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 78 | 83 | $75,667 | $5,341 | 7.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 38 | $26,946 | $2,909 | 10.8% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 20 | 24 | $26,547 | $2,534 | 9.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 67 | $73,372 | $2,488 | 3.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $6,360 | $2,369 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,024 | $1,728 | 34.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,323 | $1,452 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 19 | $2,679 | $1,143 | 42.7% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 15 | 15 | $1,090 | $199.43 | 18.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 197 | 206 | $236,752 | $35,978 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 92 | $18,615 | $8,499 | 45.7% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 23 | 25 | $26,667 | $8,126 | 30.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 100 | 110 | $100,500 | $7,922 | 7.9% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 24 | 25 | $20,082 | $6,098 | 30.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 30 | $11,682 | $4,294 | 36.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 93 | 95 | $105,308 | $3,773 | 3.6% |
| 43275 | Removal of stent from pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 12 | 12 | $10,444 | $3,382 | 32.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 36 | $25,593 | $2,714 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,200 | $2,394 | 38.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 20 | 24 | $26,853 | $2,164 | 8.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 13 | 13 | $10,640 | $2,125 | 20.0% |
About Dr. Ujjwal Kumar, M.D
Dr. Ujjwal Kumar, M.D is a Gastroenterology healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2013. The National Provider Identifier (NPI) number assigned to this provider is 1235570805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ujjwal Kumar, M.D has received a total of $2,825 in payments from pharmaceutical and medical device companies, with $1,325 received in 2024. These payments were reported across 102 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,651).
As a Medicare-enrolled provider, Kumar has provided services to 2,560 Medicare beneficiaries, totaling 2,808 services with total Medicare billing of $316,605. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Cedar Rapids, IA
- Active Since 07/11/2013
- Last Updated 12/08/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235570805
Products in Payments
- SpyGlass (Device) $778.20
- EXALT (Device) $354.48
- RINVOQ (Biological) $205.77
- HUMIRA (Biological) $175.20
- SKYRIZI (Biological) $175.03
- STELARA (Biological) $172.35
- ZEPOSIA (Drug) $116.09
- XIFAXAN (Drug) $71.39
- DUPIXENT (Biological) $68.83
- Linzess (Drug) $64.78
- REMICADE (Biological) $63.77
- ENTYVIO (Biological) $61.55
- XELJANZ (Drug) $57.83
- OCALIVA (Drug) $52.17
- DIFICID (Drug) $39.13
- LINZESS (Drug) $34.30
- SUTAB (Drug) $29.38
- Axios (Device) $25.09
- TREMFYA (Drug) $24.85
- MAVYRET (Drug) $20.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cedar Rapids
John Herlihy, M.d, M.D
Gastroenterology — Payments: $12,237
Dr. Bhavya Akhauri, M.d, M.D
Gastroenterology — Payments: $1,650
Barakat Aburajab Altamimi, M.d, M.D
Gastroenterology — Payments: $934.47
Leon Qiao, M.d, M.D
Gastroenterology — Payments: $906.67
Douglas Purdy, Md, MD
Gastroenterology — Payments: $630.24
Gary Weinman, M.d, M.D
Gastroenterology — Payments: $59.23